When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...

West Pharmaceutical stock was climbing 19% on Thursday, putting it on track for the strongest single-day percentage increase ...

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...